COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
Saved in:
| Title: | COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance. |
|---|---|
| Authors: | Bou-Antoun S; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Rokadiya S; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK., Ashiru-Oredope D; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Demirjian A; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK.; Department of Paediatric Infectious Diseases & Immunology, Evelina London Children's Hospital, London, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK., Sherwood E; Clinical and Emerging Infections (CEI), United Kingdom Health Security Agency (UKHSA), London, UK., Ellaby N; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK., Gerver S; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Grossi C; COVID-19 Rapid Evidence Service Public Health Advice, Guidance and Expertise (PHAGE), UK Health Security Agency, London NW9 5EQ, UK., Harman K; COVID-19 Vaccines and Applied Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK., Hartman H; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK., Lochen A; Tuberculosis (TB), Acute Respiratory, Zoonoses, Emerging and Travel infections Division, UK Health Security Agency, London NW9 5EQ, UK., Ragonnet-Cronin M; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK.; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.; Department of Ecology and Evolution, University of Chicago, Chicago, IL, USA., Squire H; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Sutton JM; Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.; Institute of Pharmaceutical Sciences, King's College London, London, UK., Thelwall S; COVID-19 Vaccines and Applied Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK., Tree J; Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK., Bahar MW; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK., Stuart DI; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.; Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK., Brown CS; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK., Chand M; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK., Hopkins S; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK. |
| Source: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2023 Nov 23; Vol. 78 (Suppl 2), pp. ii37-ii42. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37995354 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bou-Antoun+S%22">Bou-Antoun S</searchLink>; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Rokadiya+S%22">Rokadiya S</searchLink>; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Ashiru-Oredope+D%22">Ashiru-Oredope D</searchLink>; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Demirjian+A%22">Demirjian A</searchLink>; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK.; Department of Paediatric Infectious Diseases & Immunology, Evelina London Children's Hospital, London, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Sherwood+E%22">Sherwood E</searchLink>; Clinical and Emerging Infections (CEI), United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Ellaby+N%22">Ellaby N</searchLink>; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Gerver+S%22">Gerver S</searchLink>; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Grossi+C%22">Grossi C</searchLink>; COVID-19 Rapid Evidence Service Public Health Advice, Guidance and Expertise (PHAGE), UK Health Security Agency, London NW9 5EQ, UK.<br /><searchLink fieldCode="AU" term="%22Harman+K%22">Harman K</searchLink>; COVID-19 Vaccines and Applied Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK.<br /><searchLink fieldCode="AU" term="%22Hartman+H%22">Hartman H</searchLink>; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Lochen+A%22">Lochen A</searchLink>; Tuberculosis (TB), Acute Respiratory, Zoonoses, Emerging and Travel infections Division, UK Health Security Agency, London NW9 5EQ, UK.<br /><searchLink fieldCode="AU" term="%22Ragonnet-Cronin+M%22">Ragonnet-Cronin M</searchLink>; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK.; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.; Department of Ecology and Evolution, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Squire+H%22">Squire H</searchLink>; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Sutton+JM%22">Sutton JM</searchLink>; Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.; Institute of Pharmaceutical Sciences, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Thelwall+S%22">Thelwall S</searchLink>; COVID-19 Vaccines and Applied Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK.<br /><searchLink fieldCode="AU" term="%22Tree+J%22">Tree J</searchLink>; Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK.<br /><searchLink fieldCode="AU" term="%22Bahar+MW%22">Bahar MW</searchLink>; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Stuart+DI%22">Stuart DI</searchLink>; Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, The Wellcome Centre for Human Genetics, Oxford, UK.; Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.<br /><searchLink fieldCode="AU" term="%22Brown+CS%22">Brown CS</searchLink>; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Chand+M%22">Chand M</searchLink>; Genomics Public Health Analysis (GPHA), United Kingdom Health Security Agency (UKHSA), London, UK.<br /><searchLink fieldCode="AU" term="%22Hopkins+S%22">Hopkins S</searchLink>; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, United Kingdom Health Security Agency (UKHSA), London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227513617%22">The Journal of antimicrobial chemotherapy</searchLink> [J Antimicrob Chemother] 2023 Nov 23; Vol. 78 (Suppl 2), pp. ii37-ii42. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7513617 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2091 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203057453%22">03057453 </searchLink><i>NLM ISO Abbreviation: </i>J Antimicrob Chemother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37995354 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jac/dkad314 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: ii37 Titles: – TitleFull: COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bou-Antoun S – PersonEntity: Name: NameFull: Rokadiya S – PersonEntity: Name: NameFull: Ashiru-Oredope D – PersonEntity: Name: NameFull: Demirjian A – PersonEntity: Name: NameFull: Sherwood E – PersonEntity: Name: NameFull: Ellaby N – PersonEntity: Name: NameFull: Gerver S – PersonEntity: Name: NameFull: Grossi C – PersonEntity: Name: NameFull: Harman K – PersonEntity: Name: NameFull: Hartman H – PersonEntity: Name: NameFull: Lochen A – PersonEntity: Name: NameFull: Ragonnet-Cronin M – PersonEntity: Name: NameFull: Squire H – PersonEntity: Name: NameFull: Sutton JM – PersonEntity: Name: NameFull: Thelwall S – PersonEntity: Name: NameFull: Tree J – PersonEntity: Name: NameFull: Bahar MW – PersonEntity: Name: NameFull: Stuart DI – PersonEntity: Name: NameFull: Brown CS – PersonEntity: Name: NameFull: Chand M – PersonEntity: Name: NameFull: Hopkins S IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 11 Text: 2023 Nov 23 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1460-2091 Numbering: – Type: volume Value: 78 – Type: issue Value: Suppl 2 Titles: – TitleFull: The Journal of antimicrobial chemotherapy Type: main |
| ResultId | 1 |